Organogenesis Holdings Inc. (ORGO) insider trading

By person

18 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Alan A. Ades

Director

—

102,170,804

$272.67M

+18.9%

Albert Erani

10% owner

—

51,585,403

$137.67M

−22.3%

GN 2016 Family Trust u/a/d August 12, 2016 entity

10% owner

—

51,085,403

$136.34M

−1.9%

Gary S. Gillheeney

President and CEO

—

4,231,112

$11.29M

+79.9%

Glenn H Nussdorf

Director

—

2,901,310

$7.74M

−5.4%

Patrick Bilbo

Chief Operating Officer

—

1,127,985

$3.01M

+39.4%

Lori Freedman

Chief Admin. and Legal Officer

—

1,023,355

$2.73M

+118.1%

Brian Grow

Chief Commercial Officer

—

899,355

$2.40M

+73.0%

David Francisco

Chief Financial Officer

—

731,020

$1.95M

+70.4%

Arthur S Leibowitz

Director

—

291,014

$776.66K

+55.1%

Robert Cavorsi

Vice President, Strategy

—

275,524

$735.32K

+97.0%

Prathyusha Duraibabu

Director

—

247,047

$659.32K

+66.2%

Jon L Giacomin

Director

—

241,026

$643.25K

+69.0%

Gilberto Quintero

Director

—

239,073

$638.04K

+70.0%

Michele Ilene Korfin

Director

—

239,073

$638.04K

+70.0%

Antonio S. Montecalvo

Vice President, Health Policy

—

226,163

$603.58K

+34.4%

Michael Joseph Driscoll

Director

—

225,707

$602.37K

+58.6%

Garrett Lustig

Director

—

125,742

$335.58K

+359.9%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Organogenesis Holdings Inc.

What the insiders did No buying or selling

By person